Israel Englander Catalyst Biosciences, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.19 - $0.64 $14,685 - $49,466	77,291 Added 39.63%	272,313 $56,000
Q4 2022 Feb 14, 2023	SELL	$0.49 - $0.57 $342,853 - $398,828	-699,700 Reduced 78.2%	195,022 $103,000
Q3 2022 Nov 14, 2022	BUY	$0.49 - $1.95 $273,120 - $1.09 Million	557,388 Added 165.23%	894,722 $451,000
Q2 2022 Aug 15, 2022	SELL	$0.36 - $1.78 $108,167 - $534,827	-300,465 Reduced 47.11%	337,334 $600,000
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $138,433 - $271,439	-271,439 Reduced 29.85%	637,799 $421,000
Q4 2021 Feb 14, 2022	BUY	$0.91 - $4.16 $216,592 - $990,138	238,014 Added 35.46%	909,238 $831,000
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $440,460 - $603,594	-116,524 Reduced 14.79%	671,224 $2.76 Million
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $1.02 Million - $1.32 Million	248,474 Added 46.08%	787,748 $3.41 Million
Q1 2021 May 17, 2021	SELL	$4.93 - $7.15 $713,154 - $1.03 Million	-144,656 Reduced 21.15%	539,274 $2.72 Million
Q4 2020 Feb 16, 2021	SELL	$4.55 - $7.29 $1.21 Million - $1.94 Million	-266,005 Reduced 28.0%	683,930 $4.32 Million
Q3 2020 Nov 16, 2020	SELL	$4.22 - $6.04 $816,156 - $1.17 Million	-193,402 Reduced 16.92%	949,935 $4.09 Million
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $171,080 - $364,455	45,500 Added 4.14%	1,143,337 $6.71 Million
Q1 2020 May 14, 2020	BUY	$3.5 - $8.51 $1.33 Million - $3.24 Million	380,472 Added 53.04%	1,097,837 $4.8 Million
Q4 2019 Feb 14, 2020	BUY	$4.52 - $7.91 $63,365 - $110,890	14,019 Added 1.99%	717,365 $4.89 Million
Q3 2019 Nov 14, 2019	BUY	$4.91 - $9.31 $658,121 - $1.25 Million	134,037 Added 23.54%	703,346 $3.45 Million
Q2 2019 Aug 15, 2019	BUY	$7.08 - $10.6 $3.63 Million - $5.43 Million	512,212 Added 897.09%	569,309 $4.2 Million
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $3.6 Million - $5.39 Million	-508,244 Reduced 89.9%	57,097 $386,000
Q1 2019 May 14, 2019	BUY	$7.67 - $9.96 $2.09 Million - $2.71 Million	272,501 Added 93.05%	565,341 $4.59 Million
Q4 2018 Feb 14, 2019	SELL	$6.59 - $11.28 $362,410 - $620,332	-54,994 Reduced 15.81%	292,840 $2.31 Million
Q3 2018 Nov 14, 2018	BUY	$9.35 - $12.44 $1.25 Million - $1.67 Million	133,931 Added 62.61%	347,834 $3.75 Million
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $1.38 Million - $4.36 Million	151,103 Added 240.61%	213,903 $2.5 Million
Q1 2018 May 15, 2018	BUY	$14.18 - $35.6 $890,504 - $2.24 Million	62,800 New	62,800 $1.62 Million

Others Institutions Holding CBIO

# of Institutions

Shares Held

215

Call Options Held

Put Options Held

American Portfolios Advisors Holbrook, NY

215
Shares

$0
0.0% of portfolio

View Full List

About CATALYST BIOSCIENCES, INC.

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

More about CBIO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account